Health care companies by one-year price change
How far the share price has moved over the last 52 weeks.
Moderna leads the 170 health care companies ranked by one-year price change, at +755%, ahead of Erasca (+403%) and Kodiak Sciences (+396%). Figures as of 19 Nov 2026, 05:12 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Moderna+755%
- Median
- +24.1%
- Combined market value
- HK$71.35T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | +755% | HK$624.7B | HK$1,543.80 | 4.84% down | 755% up | ||
| 2 | ErascaERAS · Health Care | +403% | HK$37.9B | HK$107.95 | 0.94% down | 403% up | ||
| 3 | Kodiak SciencesKOD · Health Care | +396% | HK$50.2B | HK$767.31 | 1.04% up | 396% up | ||
| 4 | Twist BioscienceTWST · Health Care | +340% | HK$62.2B | HK$912.75 | 3.88% up | 340% up | ||
| 5 | Spyre TherapeuticsSYRE · Health Care | +286% | HK$75.6B | HK$795.94 | 8.15% up | 286% up | ||
| 6 | 10x GenomicsTXG · Health Care | +260% | HK$58.9B | HK$447.71 | 1.37% up | 260% up | ||
| 7 | Oruka TherapeuticsORKA · Health Care | +241% | HK$50.9B | HK$751.07 | 0.60% down | 241% up | ||
| 8 | VeradermicsMANE · Health Care | +233% | HK$41.3B | HK$979.51 | 0.62% down | 233% up | ||
| 9 | ImmunityBioIBRX · Health Care | +193% | HK$55.9B | HK$52.56 | 7.03% up | 193% up | ||
| 10 | PACS GroupPACS · Health Care | +188% | HK$57.7B | HK$363.22 | 4.63% down | 188% up | ||
| 11 | Definium TherapeuticsDFTX · Health Care | +169% | HK$31.3B | HK$228.44 | 0.88% down | 169% up | ||
| 12 | GlaukosGKOS · Health Care | +152% | HK$108.2B | HK$1,828.49 | 4.18% down | 152% up | ||
| 13 | Revolution MedicinesRVMD · Health Care | +131% | HK$271.2B | HK$1,253.77 | 1.76% down | 131% up | ||
| 14 | LifeStance Health GroupLFST · Health Care | +129% | HK$41.1B | HK$108.02 | 2.82% down | 129% up | ||
| 15 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | HK$58.6B | HK$745.66 | 0.06% down | 126% up | ||
| 16 | Concentra Group Holdings ParentCON · Health Care | +120% | HK$41.4B | HK$329.33 | 0.94% down | 120% up | ||
| 17 | BrightSpring Health ServicesBTSG · Health Care | +116% | HK$106.7B | HK$536.12 | 2.13% down | 116% up | ||
| 18 | Dianthus TherapeuticsDNTH · Health Care | +113% | HK$37.1B | HK$658.81 | 3.45% down | 113% up | ||
| 19 | Oscar HealthOSCR · Health Care | +112% | HK$67.2B | HK$216.28 | 7.61% down | 112% up | ||
| 20 | TG TherapeuticsTGTX · Health Care | +107% | HK$78.4B | HK$518.70 | 5.44% up | 107% up | ||
| 21 | Charles River Laboratories InternationalCRL · Health Care | +105% | HK$125.3B | HK$2,614.31 | 0.33% up | 105% up | ||
| 22 | CenteneCNC · Health Care | +102% | HK$262B | HK$529.14 | 7.03% down | 102% up | ||
| 23 | ViatrisVTRS · Health Care | +95.5% | HK$182.4B | HK$159.09 | 0.83% down | 96% up | ||
| 24 | HumanaHUM · Health Care | +93.7% | HK$363.5B | HK$3,026.41 | 12.98% down | 94% up | ||
| 25 | Lantheus HoldingsLNTH · Health Care | +92.8% | HK$52.3B | HK$800.18 | 0.20% up | 93% up | ||
| 26 | Roivant SciencesROIV · Health Care | +90.3% | HK$220.1B | HK$303.83 | 0.05% up | 90% up | ||
| 27 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | HK$35.5B | HK$324.54 | 1.59% down | 88% up | ||
| 28 | Adaptive BiotechnologiesADPT · Health Care | +88.1% | HK$36.1B | HK$223.27 | 0.11% down | 88% up | ||
| 29 | Kymera TherapeuticsKYMR · Health Care | +87.5% | HK$81.1B | HK$950.25 | 0.32% down | 87% up | ||
| 30 | CG OncologyCGON · Health Care | +85.3% | HK$56.1B | HK$627.59 | 1.34% up | 85% up | ||
| 31 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | HK$59.8B | HK$171.65 | 3.60% up | 83% up | ||
| 32 | Royalty PharmaRPRX · Health Care | +77.7% | HK$309.8B | HK$538.71 | 0.01% down | 78% up | ||
| 33 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | HK$386.6B | HK$331.29 | 0.92% down | 74% up | ||
| 34 | HeartflowHTFL · Health Care | +72.9% | HK$31.6B | HK$360.00 | 2.51% down | 73% up | ||
| 35 | LivaNovaLIVN · Health Care | +70.5% | HK$40.9B | HK$741.66 | 2.85% up | 71% up | ||
| 36 | GenmabGMAB · Health Care | +70.0% | HK$246.5B | HK$399.85 | 1.91% down | 70% up | ||
| 37 | IlluminaILMN · Health Care | +68.7% | HK$249.1B | HK$1,647.51 | 3.65% up | 69% up | ||
| 38 | ExelixisEXEL · Health Care | +62.6% | HK$130.7B | HK$535.73 | 0.31% down | 63% up | ||
| 39 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | HK$66.9B | HK$2,394.19 | 0.04% up | 61% up | ||
| 40 | HaemoneticsHAE · Health Care | +60.8% | HK$43.9B | HK$963.82 | 1.60% up | 61% up | ||
| 41 | West Pharmaceutical ServicesWST · Health Care | +60.6% | HK$220.8B | HK$3,169.50 | 2.44% down | 61% up | ||
| 42 | RevvityRVTY · Health Care | +60.2% | HK$133.5B | HK$1,195.80 | 3.14% up | 60% up | ||
| 43 | Molina HealthcareMOH · Health Care | +60.2% | HK$84.6B | HK$1,620.44 | 6.62% down | 60% up | ||
| 44 | AlkermesALKS · Health Care | +58.4% | HK$61.8B | HK$367.53 | 3.08% up | 58% up | ||
| 45 | Takeda PharmaceuticalTAK · Health Care | +53.6% | HK$533.1B | HK$166.86 | 1.71% down | 54% up | ||
| 46 | TeleflexTFX · Health Care | +50.9% | HK$51.6B | HK$1,301.08 | 3.95% up | 51% up | ||
| 47 | Merck & CoMRK · Health Care | +50.8% | HK$2.66T | HK$1,080.87 | 3.90% down | 51% up | ||
| 48 | DaVitaDVA · Health Care | +50.2% | HK$79.8B | HK$1,269.23 | 6.48% down | 50% up | ||
| 49 | BiogenBIIB · Health Care | +49.3% | HK$291.5B | HK$1,972.29 | 0.25% up | 49% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | HK$65.1B | HK$997.56 | 2.00% up | 46% up | ||
| 51 | Krystal BiotechKRYS · Health Care | +46.3% | HK$73.3B | HK$2,473.81 | 5.62% up | 46% up | ||
| 52 | Baxter InternationalBAX · Health Care | +45.6% | HK$106.2B | HK$205.22 | 1.55% up | 46% up | ||
| 53 | Tenet HealthcareTHC · Health Care | +45.2% | HK$169.4B | HK$2,128.64 | 3.80% down | 45% up | ||
| 54 | Travere TherapeuticsTVTX · Health Care | +44.2% | HK$37.8B | HK$394.13 | 1.68% down | 44% up | ||
| 55 | Guardant HealthGH · Health Care | +43.9% | HK$154B | HK$1,138.61 | 1.30% up | 44% up | ||
| 56 | ImmunovantIMVT · Health Care | +43.4% | HK$53.9B | HK$260.22 | 0.12% down | 43% up | ||
| 57 | Becton, DickinsonBDX · Health Care | +43.3% | HK$461.7B | HK$1,695.13 | 0.31% up | 43% up | ||
| 58 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | HK$46.9B | HK$2,343.35 | 1.67% up | 43% up | ||
| 59 | Bausch + LombBLCO · Health Care | +42.5% | HK$58.8B | HK$164.35 | 0.58% up | 42% up | ||
| 60 | BrukerBRKR · Health Care | +41.4% | HK$75.8B | HK$496.27 | 3.10% up | 41% up | ||
| 61 | Labcorp HoldingsLH · Health Care | +41.3% | HK$236.2B | HK$2,908.73 | 0.69% up | 41% up | ||
| 62 | AvantorAVTR · Health Care | +37.9% | HK$81.7B | HK$120.58 | 1.25% up | 38% up | ||
| 63 | Quest DiagnosticsDGX · Health Care | +37.9% | HK$224.1B | HK$2,037.24 | 1.30% up | 38% up | ||
| 64 | Johnson & JohnsonJNJ · Health Care | +37.6% | HK$5.15T | HK$2,139.30 | 2.15% down | 38% up | ||
| 65 | DexComDXCM · Health Care | +37.4% | HK$241.4B | HK$647.36 | 0.59% up | 37% up | ||
| 66 | Elevance HealthELV · Health Care | +37.2% | HK$679.4B | HK$3,144.55 | 7.63% down | 37% up | ||
| 67 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | HK$124.8B | HK$1,943.73 | 2.93% up | 37% up | ||
| 68 | Halozyme TherapeuticsHALO · Health Care | +36.6% | HK$85.7B | HK$751.54 | 0.18% down | 37% up | ||
| 69 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | HK$767.3B | HK$7,417.59 | 1.28% down | 36% up | ||
| 70 | Eli LillyLLY · Health Care | +34.9% | HK$9.66T | HK$10,847.54 | 2.32% down | 35% up | ||
| 71 | Cardinal HealthCAH · Health Care | +34.6% | HK$504.7B | HK$2,183.39 | 0.33% down | 35% up | ||
| 72 | Bristol-Myers SquibbBMY · Health Care | +34.0% | HK$955.1B | HK$467.24 | 2.92% down | 34% up | ||
| 73 | AmgenAMGN · Health Care | +33.7% | HK$1.88T | HK$3,482.27 | 3.07% down | 34% up | ||
| 74 | Gilead SciencesGILD · Health Care | +32.9% | HK$1.64T | HK$1,325.63 | 0.75% down | 33% up | ||
| 75 | NateraNTRA · Health Care | +31.7% | HK$329.3B | HK$2,271.10 | 0.71% up | 32% up | ||
| 76 | Belite BioBLTE · Health Care | +31.0% | HK$49.8B | HK$1,225.61 | 0.94% down | 31% up | ||
| 77 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | HK$47.4B | HK$725.57 | 0.59% up | 31% up | ||
| 78 | McKessonMCK · Health Care | +28.1% | HK$982.2B | HK$8,507.24 | 0.66% down | 28% up | ||
| 79 | Ascendis PharmaASND · Health Care | +27.8% | HK$139.1B | HK$2,120.71 | 0.32% down | 28% up | ||
| 80 | ChemedCHE · Health Care | +27.2% | HK$55.6B | HK$4,288.96 | 0.01% down | 27% up | ||
| 81 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | HK$1.07T | HK$4,208.40 | 0.42% up | 27% up | ||
| 82 | UnitedHealth GroupUNH · Health Care | +26.1% | HK$2.46T | HK$2,745.01 | 10.21% down | 26% up | ||
| 83 | AbbVieABBV · Health Care | +25.7% | HK$3.97T | HK$2,243.72 | 2.33% down | 26% up | ||
| 84 | Bio-TechneTECH · Health Care | +25.6% | HK$89.7B | HK$570.72 | 0.17% up | 26% up | ||
| 85 | NovartisNVS · Health Care | +25.0% | HK$2.3T | HK$1,217.61 | 2.46% down | 25% up | ||
| 86 | Encompass HealthEHC · Health Care | +23.2% | HK$103.9B | HK$1,058.51 | 2.14% down | 23% up | ||
| 87 | ICONICLR · Health Care | +22.8% | HK$114.7B | HK$1,531.01 | 0.07% up | 23% up | ||
| 88 | United TherapeuticsUTHR · Health Care | +22.6% | HK$192.9B | HK$4,529.17 | 1.16% down | 23% up | ||
| 89 | Edwards LifesciencesEW · Health Care | +22.6% | HK$474.7B | HK$825.52 | 0.19% down | 23% up | ||
| 90 | Align TechnologyALGN · Health Care | +22.3% | HK$90.7B | HK$1,286.25 | 0.31% up | 22% up | ||
| 91 | VaxcytePCVX · Health Care | +22.2% | HK$72.7B | HK$459.08 | 1.48% down | 22% up | ||
| 92 | Mettler-Toledo InternationalMTD · Health Care | +22.0% | HK$271.1B | HK$13,628.63 | 1.42% up | 22% up | ||
| 93 | Elanco Animal HealthELAN · Health Care | +20.5% | HK$104.7B | HK$209.46 | 3.29% up | 20% up | ||
| 94 | GRAILGRAL · Health Care | +20.4% | HK$36B | HK$800.96 | 3.57% down | 20% up | ||
| 95 | Neurocrine BiosciencesNBIX · Health Care | +20.2% | HK$129.3B | HK$1,277.62 | 1.84% down | 20% up | ||
| 96 | Thermo Fisher ScientificTMO · Health Care | +19.7% | HK$2.01T | HK$5,434.48 | 0.87% up | 20% up | ||
| 97 | WatersWAT · Health Care | +19.5% | HK$718.6B | HK$3,656.51 | 3.63% up | 20% up | ||
| 98 | Agilent TechnologiesA · Health Care | +19.3% | HK$392.3B | HK$1,391.14 | 2.97% up | 19% up | ||
| 99 | IQVIA HoldingsIQV · Health Care | +18.4% | HK$333.3B | HK$2,022.73 | 0.09% up | 18% up | ||
| 100 | IncyteINCY · Health Care | +17.5% | HK$188.4B | HK$924.13 | 1.08% down | 18% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 7.8449 HKD).
Questions and answers
Which health care companies rank first by one-year price change?
Moderna (+755%), Erasca (+403%) and Kodiak Sciences (+396%) are the top three of the 170 health care companies ranked by one-year price change as of 19 Nov 2026, 05:12 UTC.
How many health care companies are in this ranking?
170 are ranked by one-year price change.
What are these health care companies worth together?
The 170 health care companies ranked by one-year price change have a combined market value of HK$71.35T as of 19 Nov 2026, 05:12 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.